About Vanta Clinical Research Limited
Data last updated: 18 February 2026
Vanta Clinical Research Limited is a public limited company based in Secunderabad, Telangana, India, a subsidiary of Vanta Bioscience Limited. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 12 September 2018, the company has been in operation for over 8 years.
Registered with ROC Hyderabad under CIN U73100TG2018PLC126673.
Capital: an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Dopesh Raja Mulakala and Shravan Chintapatla.
Last AGM: 30 November 2021. Financial statements filed for year ended 31 March 2021. Office: No.02/G/308/G No.3/Ff/Sf/1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003.
As per the financials filed for FY 2021, the company reported a revenue of ₹1,983, a decline of 100% compared to the previous year.
It operates as a subsidiary of Vanta Bioscience Limited. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Vanta Bioscience. As per MCA filings, the company has open charges of ₹30.01 Cr and satisfied charges of ₹17 Cr on record.
For more details, the company can be reached via its website vantabio.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressNo.02/G/308/G No.3/Ff/Sf/1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Vanta Clinical Research Limited
Vanta Clinical Research Limited operates one associated brand: Vanta Bioscience. These brands represent Vanta Clinical Research Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| GLP-certified preclinical contract research services are provided. | vantabio.com |
Competitors & Alternatives of Vanta Clinical Research Limited
Brands and companies operating in the same space as Vanta Clinical Research Limited include PHAXIAM, Gubra, BioQual and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
PHAXIAM
|
Antibacterial treatments using bacteriophages are developed for resistant infections. | Lyon, France, France | 2004 |
Gubra
|
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided. | Horsholm, Denmark, Denmark | 2008 |
BioQual
|
Contract research on infectious disease models is conducted. | Rockville, United States, United States | 1981 |
Tigermed
|
Drug development and preclinical services are provided by Tigermed. | Hangzhou, China, China | 2004 |
Gentronix
|
In-vitro and in-vivo genetic toxicology screening services are provided. | Alderley Edge, United Kingdom, United Kingdom | 1999 |
Aquila BioMedical
|
Preclinical services in immunology, regeneration, neuroscience, and histology are provided. | Edinburgh, United Kingdom, United Kingdom | 2011 |
ReveraGen
|
Steroids for Duchenne muscular dystrophy treatment are developed. | Rockville, United States, United States | 2008 |
VGXI
|
Contract developer and manufacturer of plasmids | The Woodlands, United States, United States | 1997 |
Shanghai Semero Biotechnology
|
Diversified preclinical services for brain-related disorders are provided. | Shanghai, China, China | 2014 |
Auditor Details of Vanta Clinical Research Limited
Vanta Clinical Research Limited is audited by ITALIA & ASSOCIATES LLP for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ITALIA & ASSOCIATES LLP | Locked | Locked | Locked |
Complete auditor history for Vanta Clinical Research Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vanta Clinical Research Limited
Vanta Clinical Research Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dopesh Raja Mulakala | Director | 12 Sep 2018 | 7 Years 10 Months | Current |
| Shravan Chintapatla | Director | 18 Aug 2020 | 5 Years 11 Months | Current |
| Mulakala Sajan Kiran | Director | 07 Mar 2020 | 6 Years 4 Months | Current |
Financials of Vanta Clinical Research Limited FY 2021 filings available
Vanta Clinical Research Limited reported revenue of ₹1,983 (down 100.00% YoY) for FY 2021.
Ten-year financial statements for Vanta Clinical Research Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Vanta Clinical Research Limited
Shareholding and ownership data for Vanta Clinical Research Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Vanta Clinical Research Limited
Vanta Clinical Research Limited has 1 subsidiary company. This group structure data is as of FY 2021. The corporate group structure reflects Vanta Clinical Research Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Vayam Research Solutions Limited | U73100TG2018PLC127550 | Locked |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Vanta Clinical Research Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2022 | Others | ₹19.97 Cr | Open |
| 01 Jul 2020 | State Bank of India | ₹10.04 Cr | Open |
| 03 Dec 2019 | Axis Bank Limited | ₹17 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Vanta Clinical Research Limited
View historical data on people associated with Vanta Clinical Research Limited, including employment history and EPFO contributions.
Employee and EPFO history for Vanta Clinical Research Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Vanta Clinical Research Limited
GST registrations and filing compliance for Vanta Clinical Research Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Vanta Clinical Research Limited
Credit ratings, litigation, and regulatory alerts for Vanta Clinical Research Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vanta Clinical Research Limited
MSME payment history for Vanta Clinical Research Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vanta Clinical Research Limited
Corporate group structure for Vanta Clinical Research Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vanta Clinical Research Limited
MCA filings and documents for Vanta Clinical Research Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Vanta Clinical Research Limited
Recent News on Vanta Clinical Research Limited
Frequently Asked Questions about Vanta Clinical Research Limited
Vanta Clinical Research Limited is an active public limited company in the pharma sector based in Secunderabad, Telangana, India. It was incorporated on 12 September 2018 (8+ years old) and is registered under CIN U73100TG2018PLC126673.
Vanta Clinical Research Limited reported revenue of ₹1,983 for FY 2021 (down 100.00% YoY).
The current directors of Vanta Clinical Research Limited are:
- Dopesh Raja Mulakala - Director
- Shravan Chintapatla - Director
- Mulakala Sajan Kiran - Director
The primary industry of Vanta Clinical Research Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.
Vanta Clinical Research Limited can be reached at the registered office: No.02G308G No.3FfSf1 – 20 – 248 Umajay Complex Rasoolpura, Secunderabad, Telangana, India – 500003, or through the website vantabio.com.
The authorised capital is ₹3 Cr, and the paid-up capital is ₹3 Cr.